Patents Assigned to Zywie, LLC
  • Modified forms of ambroxol for therapeutic use
    Patent number: 12668567
    Abstract: The invention relates to analog forms of ambroxol and related compounds, compositions comprising same, and methods of preventing and/or treating various diseases and medical conditions involving the administration of analogs of ambroxol and related compounds.
    Type: Grant
    Filed: July 22, 2024
    Date of Patent: June 30, 2026
    Assignee: Zywie, LLC
    Inventors: Stephen Anderson, Stephen Pasternak, Vincent Jacques, Gerard Joseph Broussard, Jr.
  • MODIFIED FORMS OF AMBROXOL FOR THERAPEUTIC USE
    Publication number: 20250235413
    Abstract: The invention relates to polydeuterated analog forms of ambroxol and related compounds (including bromhexine and the ambroxol salt, ambroxol hydrochloride), compositions comprising same, and methods of preventing and/or treating various diseases and medical conditions involving the administration of polydeuterated analogs of ambroxol and related compounds.
    Type: Application
    Filed: October 27, 2022
    Publication date: July 24, 2025
    Applicant: Zywie, LLC
    Inventors: Stephen Anderson, Stephen Pasternak, Vincent Jacques, Gerard Joseph Broussard, JR.
  • MODIFIED FORMS OF AMBROXOL FOR THERAPEUTIC USE
    Publication number: 20250011277
    Abstract: The invention relates to analog forms of ambroxol and related compounds, compositions comprising same, and methods of preventing and/or treating various diseases and medical conditions involving the administration of analogs of ambroxol and related compounds.
    Type: Application
    Filed: July 22, 2024
    Publication date: January 9, 2025
    Applicant: Zywie, LLC
    Inventors: Stephen Anderson, Stephen Pasternak, Vincent Jacques, Gerard Joseph Broussard, JR.